ANI Pharmaceuticals : Corporate Presentation May 2026
ANI Pharmaceuticals Inc ANIP
$78.01
▼ -1.97%
($-1.57)
Open
$79.28
Prev Close
$79.58
Day Range
$76.67 – $80.00
52W Range
$56.71 – $99.50
Market Cap
$1.77B
P/E (TTM)
23.05
Beta
0.46
EPS (TTM)
$3.70
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2000-05-04 |
| Shares Out. | 22,760,000 |
| Website | anipharmaceuticals.com/ ↗ |
| Phone | 12186343500 |
ANI Pharmaceuticals Inc is a publicly traded company under the ticker symbol ANIP on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-05-01)
📰 Latest News for ANIP
ANI Pharmaceuticals, Inc. announces an Equity Buyback for $100 million worth of its shares.
ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call Transcript
ANI Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation
ANI Pharmaceuticals (NASDAQ:ANIP) Crushes Q1 Estimates, Raises Full-Year Guidance
ANI Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Transcript : ANI Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 08, 2026
ANI: Q1 Earnings Snapshot